MoneyWorks4Me

Jagsonpal Pharmaceuticals informs about disclosure

05 Oct 2018 Evaluate

Jagsonpal Pharmaceuticals has informed about disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

The above information is a part of company’s filings submitted to BSE.


Peers
Company Name CMP
Sun Pharma. Inds. 1752.10
Dr. Reddys Labs. 1232.90
Cipla 1330.60
Lupin 1966.30
Zydus Lifesciences 1123.10
View more..